These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1812361)

  • 1. Liposomes as MR contrast agents: pros and cons.
    Unger E; Shen DK; Wu GL; Fritz T
    Magn Reson Med; 1991 Dec; 22(2):304-8; discussion 313. PubMed ID: 1812361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese-based liposomes. Comparative approaches.
    Unger E; Fritz T; Shen DK; Wu G
    Invest Radiol; 1993 Oct; 28(10):933-8. PubMed ID: 8262748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
    Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
    Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of liposomes as MR contrast agents.
    Unger EC; Shen DK; Fritz TA
    J Magn Reson Imaging; 1993; 3(1):195-8. PubMed ID: 8428087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents.
    Schwendener RA; Wüthrich R; Duewell S; Wehrli E; von Schulthess GK
    Invest Radiol; 1990 Aug; 25(8):922-32. PubMed ID: 2394576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of tumor angiogenesis using sterically stabilized Gd-DTPA liposomes targeted to CD105.
    Zhang D; Feng XY; Henning TD; Wen L; Lu WY; Pan H; Wu X; Zou LG
    Eur J Radiol; 2009 Apr; 70(1):180-9. PubMed ID: 18541399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and clearance of liposomal gadolinium-DTPA.
    Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
    Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging.
    Niesman MR; Bacic GG; Wright SM; Swartz HJ; Magin RL
    Invest Radiol; 1990 May; 25(5):545-51. PubMed ID: 2345086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress.
    Unger E; Needleman P; Cullis P; Tilcock C
    Invest Radiol; 1988 Dec; 23(12):928-32. PubMed ID: 3203995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
    Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
    Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
    Tilcock C; Unger E; Cullis P; MacDougall P
    Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
    Boehm-Sturm P; Haeckel A; Hauptmann R; Mueller S; Kuhl CK; Schellenberger EA
    Radiology; 2018 Feb; 286(2):537-546. PubMed ID: 28880786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model.
    Leander P; Månsson S; Ege T; Besjakov J
    Acta Radiol; 1996 May; 37(3 Pt 1):242-9. PubMed ID: 8845249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability of liposomal membranes to water: results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions.
    Koenig SH; Ahkong QF; Brown RD; Lafleur M; Spiller M; Unger E; Tilcock C
    Magn Reson Med; 1992 Feb; 23(2):275-86. PubMed ID: 1549042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron(III)-Based Magnetic Resonance-Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery.
    Kneepkens E; Fernandes A; Nicolay K; Grüll H
    Invest Radiol; 2016 Nov; 51(11):735-745. PubMed ID: 27309776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy.
    Devoisselle JM; Vion-Dury J; Galons JP; Confort-Gouny S; Coustaut D; Canioni P; Cozzone PJ
    Invest Radiol; 1988 Oct; 23(10):719-24. PubMed ID: 3192394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
    Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K
    Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic liposomes as a bimodal carrier for magnetic resonance imaging contrast agent and photosensitizer.
    Skupin-Mrugalska P; Sobotta L; Warowicka A; Wereszczynska B; Zalewski T; Gierlich P; Jarek M; Nowaczyk G; Kempka M; Gapinski J; Jurga S; Mielcarek J
    J Inorg Biochem; 2018 Mar; 180():1-14. PubMed ID: 29223825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.